Kliniske studier for Lymfom i Florida
25 studier for Lymfom søker deltakere på steder i Florida.
Byer i Florida
Offisiell studietekst (engelsk)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Moffit Cancer Center, Tampa
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07192471A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07015242Precise Oncology Interventions in Nutrition and Training (OnPoint)
- University of Miami, Miami
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06534918A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- University of Miami, Coral Gables
- Florida Cancer Specialists, Sarasota
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07221500AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, Miami
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06137144CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Johns Hopkins All Children's Hospital, St. Petersburg
RekruttererFase 1/2
12 Months – 21 Years · Alle kjønn · Oppdatert 11. sep. 2026 · NCT04870944A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- AdventHealth Cancer Institute, Orlando
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06624085A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- University of Miami, Coral Gables
- Moffitt Cancer Center, Tampa
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06084936Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT04588922Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Mayo Clinic, Clinical Trials Referral Office, Jacksonville
RekruttererFase 1/2
Alder 13 til 90 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Mayo Clinic Florida, Jacksonville
- AdventHealth, Orlando
- Moffitt Cancer Center, Tampa
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Baptist Health Miami Cancer Institute, Miami
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT04792489A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- University of Miami, Miami
- Florida Cancer Specialists, Sarasota
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT05131022CD4CAR for CD4+ Leukemia and Lymphoma
- University of Miami Sylvester Comprehensive Cancer Center, Miami
RekruttererFase 1
Alder 12 og eldre · Alle kjønn · Oppdatert 24. jun. 2026 · NCT03829540A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site, Tampa
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. jun. 2026 · NCT05475925Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- University of Miami, Miami
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 1. jun. 2026 · NCT05663502xDRIVE for Florida-based Cancer Patients
- First Ascent Biomedical, Miami
Rekrutterer
Alle aldre · Alle kjønn · Oppdatert 19. mai 2026 · NCT07167381Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Nemours Children's Clinic-Jacksonville, Jacksonville
- Nemours Children's Hospital, Orlando
- og 2 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT01790152CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Jacksonville
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT03328078The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- ASCLEPES Research Centers, Weeki Wachee
RekruttererFase 1/2
Alder 12 til 95 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT04329728A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Miami, Miami
RekruttererFase 2
Alder 18 til 66 · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06859424A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
- University of Miami Sylvester Cancer Center, Miami
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT05800366Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Sylvester Comprehensive Cancer Center, Miami
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 20. feb. 2026 · NCT05745285A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
- Hematology-Oncology Associates of the Treasure Coast, Port Saint Lucie
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 4. feb. 2026 · NCT05892718cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Miami Cancer Institute, Miami
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.